Global HEK293 Cell Line Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global HEK293 Cell Line Market Research Report 2024
The HEK293 cell line is a permanent line established from primary embryonic human kidney, which was transformed with sheared human adenovirus type 5 DNA. The adenoviral genes expressed in this cell line allow the cells to produce very high levels of recombinant proteins.
Due to the multiple copies of adenovirus E1A and E1B genes, HEK293 cells have a high transfection efficiency. This makes them useful in biotechnology, especially protein expression, gene therapy and vaccine production.
The pharmaceutical industry uses HEK293 cells for high-throughput screening assays because they can be transfected with plasmids encoding drug targets and grown in large numbers.
In industrial biotechnology, HEK293 cells are used to produce recombinant proteins and enzymes and to develop biosensors. Toxicology researchers, on the other hand, use HEK293 cells to study the effects of chemicals and environmental toxins on cellular processes and gene expression.
HEK293 cells are also used to produce recombinant viruses, such as adenoviruses and lentiviruses, for gene therapy, viral replication, and host-virus interactions.
Overall, the HEK293 cell line is versatile and can be used in biomedical research with applications in biotechnology, pharmaceuticals, and toxicology.
According to MRAResearch’s new survey, global HEK293 Cell Line market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole HEK293 Cell Line market research.
Increasing demand for HEK293 cell lines, development of biomedical research technologies, clinical applications of cell therapy and gene therapy, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth of the HEK293 cell line market revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global HEK293 Cell Line market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Altogen Biosystems
ATCC
Synthego
CLS
Thermo Fisher Scientific
Beckman Coulter
Sigma Aldrich
Sartorius
Promega
Kerafast
Biocompare
InvivoGen
Innoprot
Takara
Henan Punuoyi Biological
Porton Pharma Solutions
Ubigene Biosciences
Segment by Type
293T
293H
293E
293F
293S
293SGGD
Others
Protein Production
Receptor Signal Transduction
Drug Testing
Cancer Research
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The HEK293 Cell Line report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Due to the multiple copies of adenovirus E1A and E1B genes, HEK293 cells have a high transfection efficiency. This makes them useful in biotechnology, especially protein expression, gene therapy and vaccine production.
The pharmaceutical industry uses HEK293 cells for high-throughput screening assays because they can be transfected with plasmids encoding drug targets and grown in large numbers.
In industrial biotechnology, HEK293 cells are used to produce recombinant proteins and enzymes and to develop biosensors. Toxicology researchers, on the other hand, use HEK293 cells to study the effects of chemicals and environmental toxins on cellular processes and gene expression.
HEK293 cells are also used to produce recombinant viruses, such as adenoviruses and lentiviruses, for gene therapy, viral replication, and host-virus interactions.
Overall, the HEK293 cell line is versatile and can be used in biomedical research with applications in biotechnology, pharmaceuticals, and toxicology.
According to MRAResearch’s new survey, global HEK293 Cell Line market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole HEK293 Cell Line market research.
Increasing demand for HEK293 cell lines, development of biomedical research technologies, clinical applications of cell therapy and gene therapy, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth of the HEK293 cell line market revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global HEK293 Cell Line market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Altogen Biosystems
ATCC
Synthego
CLS
Thermo Fisher Scientific
Beckman Coulter
Sigma Aldrich
Sartorius
Promega
Kerafast
Biocompare
InvivoGen
Innoprot
Takara
Henan Punuoyi Biological
Porton Pharma Solutions
Ubigene Biosciences
Segment by Type
293T
293H
293E
293F
293S
293SGGD
Others
Segment by Application
Protein Production
Receptor Signal Transduction
Drug Testing
Cancer Research
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The HEK293 Cell Line report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source